Cigna Corporation

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +42

What You Need to Know Ahead of The Cigna Group’s Earnings Release - Yahoo Finance

Company update Earnings report AI-generated analysis

📅 CI is scheduled to report Q3 earnings on Thursday, November 5, 2026, before the market opens.

💰 Analysts expect diluted EPS of $7.46 for Q3 2026, down 4.7% from $7.83 in the year-ago quarter.

📈 CI has exceeded Wall Street's EPS estimates in each of the past four quarters despite current expectations.

🔮 For fiscal 2026, analysts project EPS of $30.50, up 2.2% from fiscal 2025, with further growth to $33.46 in fiscal 2027.

📉 CI stock has declined 5.8% over the past 52 weeks, underperforming the S&P 500 and the Health Care Select Sector SPDR ETF.

👥 The company faces concerns about customer retention, with its customer base declining by an average of 8.1% over the past two years.

💵 Revenue has grown at an annual rate of 13.8% over the past two years, while EPS increased by 12% annually over the last five years.

🏥 CI introduced 'Health Sense,' a personalized support model targeting oncology and cardiometabolic conditions to reduce inefficient healthcare spending by 10% by 2030.

📈 Following the Health Sense announcement, CI shares rose 1.1% in the market.

👍 Analysts maintain a consensus 'Moderate Buy' rating on CI stock with an average price target of $342.26.

Bullish Signals
  • The Cigna Group has exceeded Wall Street's EPS estimates in each of the past four quarters, demonstrating a consistent track record of earnings outperformance.
  • Revenue has grown at an annual rate of 13.8% over the past two years, indicating strong underlying business growth despite customer retention challenges.
  • EPS has increased by 12% annually over the last five years, reflecting sustained profitability and operational efficiency.
  • The launch of 'Health Sense' is projected to reduce inefficient healthcare spending by 10% by 2030, potentially improving margins and patient outcomes.
  • Following the announcement of Health Sense, CI shares rose 1.1%, indicating positive market reaction to the new initiative.
  • Analysts maintain a consensus 'Moderate Buy' rating on CI stock, with 14 out of 23 analysts recommending a 'Strong Buy'.
Risk Factors
  • Analysts expect diluted EPS of $7.46 for Q3 2026, representing a 4.7% decline from the year-ago figure of $7.83.
  • CI stock has declined 5.8% over the past 52 weeks, significantly underperforming both the S&P 500 and the Health Care Select Sector SPDR ETF.
  • The company faces concerns about customer retention, with its customer base declining by an average of 8.1% over the past two years.
Full Analysis
The Cigna Group (CI), headquartered in Bloomfield, Connecticut, is a global health company serving over 185 million customer relationships across more than 30 markets. With a market capitalization of $74.6 billion, the company is preparing to report its Q3 earnings on Thursday, November 5, 2026, before the market opens. Ahead of the earnings release, analysts project diluted EPS of $7.46 for the quarter, representing a 4.7% decline from the year-ago figure of $7.83. Despite this expected dip, CI has exceeded Wall Street's EPS estimates in each of the past four quarters, highlighting a consistent track record of earnings outperformance. Looking further ahead, fiscal 2026 analysts expect CI to report EPS of $30.50, up 2.2% from fiscal 2025, with projections reaching $33.46 for fiscal 2027. Over the past two years, revenue has grown at an annual rate of 13.8%, while EPS has increased by 12% annually over the last five years. CI stock has underperformed the broader market and healthcare sector over the past 52 weeks, declining 5.8% compared to gains for the S&P 500 and the State Street Health Care Select Sector SPDR ETF. However, the company recently introduced 'Health Sense,' a personalized support model aimed at reducing inefficient healthcare spending by 10% by 2030, which caused shares to rise 1.1% following the announcement.